HomeBCTX • NASDAQ
add
Briacell Therapeutics Corp
Previous close
$3.34
Day range
$3.32 - $3.38
Year range
$2.81 - $29.40
Market cap
29.77M CAD
Avg Volume
2.20M
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Financials
Income Statement
Revenue
Net income
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.17M | -27.06% |
Net income | -6.29M | 44.30% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.14M | 27.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.01M | -19.71% |
Total assets | 9.36M | -23.44% |
Total liabilities | 6.14M | -70.14% |
Total equity | 3.23M | — |
Shares outstanding | 3.71M | — |
Price to book | 2.74 | — |
Return on assets | -181.25% | — |
Return on capital | -516.54% | — |
Cash Flow
Net change in cash
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -6.29M | 44.30% |
Cash from operations | -5.92M | 20.01% |
Cash from investing | -75.00K | — |
Cash from financing | 5.22M | — |
Net change in cash | -778.61K | 89.48% |
Free cash flow | -3.65M | -4.35% |
About
Founded
2006
Headquarters
Website
Employees
17
